Exploiting the angiotensin-converting enzyme pathway to augment endogenous opioid signaling.

Since some of the lead compounds showed a trend toward selectivity for the C-domain in our in vitro enzymatic assays, an attempt was made to validate those results using this computational approach.

also in 53,322 other papers